Literature DB >> 22641161

Sexual dysfunction: C. histolyticum collagenase effective against Peyronie.

Melanie Clyne.   

Abstract

Entities:  

Year:  2012        PMID： 22641161     DOI： 10.1038/nrurol.2012.113

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease.

Authors:  Martin Gelbard; Larry I Lipshultz; James Tursi; Ted Smith; Greg Kaufman; Laurence A Levine
Journal:  J Urol       Date:  2012-04-13       Impact factor: 7.450
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.